Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

Bile acid control of commensal-specific immune responses

Award Number: U01AI201086
ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES
OPDIV: NIH
AWARD CLASS: COOPERATIVE AGREEMENT
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 07/24/2026
PERIOD OF PERFORMANCE END DATE: 05/31/2031

Group Awards By:

View Award Description

Bile acid control of commensal-specific immune responses - Summary Bile acids (BAs) are essential gastrointestinal (GI) metabolites with dual roles in lipid absorption and cell signaling, including in immune cells. Both ‘primary’ BAs–synthesized in hepatocytes–and ‘secondary’ BA species and metabolites, produced via gut microbial metabolism, dynamically engage host nuclear receptors (NRs) and GPCRs following their intestinal absorption to modulate mucosal immune cell function and inflammation. However, current efforts to understand BA-dependent immune regulation center on functions of individual BA species and lack physiological grounding as it relates to BA enterohepatic circulation. This overlooks the composite nature of complex endogenous BA pools that interface with mucosal immune cells in situ and does not consider how the size or complexity of endogenous BA pools might be influenced by microbial colonization or infection of the intestines. Our team has developed a unique set of tools and expertise that enable quantification and manipulation of enterohepatic BA pools in vitro and in vivo. Using these systems, we have found that colonization of the model mouse commensal organism, segmented filamentous bacteria (SFB), in the ileum–the sole and dedicated site of active intestinal BA absorption–acutely remodels the pool of BAs which circulates enterohepatically through the ileal mucosa. Our team has previously shown that SFB induce a unique anti-inflammatory population of commensal-specific Th17 cells in the ileum. Our new data indicate that BAs produced in response to SFB colonization contribute directly to the induction of these Th17 cells and to establishment of their anti-inflammatory phenotype, including IL-10 production. We have also mapped a series of novel and competitive BA-NR interactions that occur at physiological BA concentrations in the ileum, are dysregulated during Crohn’s disease-like ileitis and tune activities of key immunoregulatory NRs, including RORɣt and PPARɣ, expressed in ileal Th17 and myeloid cells, respectively. Building off these insights, our goal is to elucidate how microbiota-driven shifts in enterohepatically cycling BA pools impact commensal-specific immune responses necessary for intestinal homeostasis. Using SFB as a model, our hypothesis is that commensal colonization of the ileum reprograms host hepatic BA biosynthesis to establish an enterohepatic BA pool in the ileal mucosa that direct development of tolerogenic Th17 cells through modulation of PPARɣ and RORɣ signaling in macrophages and T cells, respectively. This hypothesis will be pursued through two complementary, but not inter-dependent, Aims, and the results will elucidate how dynamically regulated BA–NR circuits balance tolerogenic vs. inflammatory functions during commensal-specific T cell responses. More broadly, we anticipate our studies will lay the foundation for rationally designing novel BA-based therapeutic strategies to promote intestinal immune tolerance and restore homeostasis in settings of enteric infectious or inflammatory diseases, including inflammatory bowel diseases (IBDs).


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = $561,873 )
2026	2026	DARTMOUTH-HITCHCOCK CLINIC	1 MEDICAL CENTER DR	LEBANON	NH	03756	GRAFTON	USA	Allergy and Infectious Diseases Research	000	1	7/23/2026	NEW	$561,873
														Subtotal = $561,873

Grand Total All Awards = $561,873

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Bile acid control of commensal-specific immune responses

Award Number: U01AI201086

ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES

OPDIV: NIH

AWARD CLASS: COOPERATIVE AGREEMENT

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 07/24/2026

PERIOD OF PERFORMANCE END DATE: 05/31/2031

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer